Length of Treatment with Colchicine
For acute gout, treat with colchicine 1.2 mg followed by 0.6 mg one hour later as a single-day regimen, then continue prophylactic dosing (0.6 mg once or twice daily) until the attack completely resolves. For gout prophylaxis when initiating urate-lowering therapy, continue for at least 6 months OR 3 months after achieving target serum urate (whichever is longer). For familial Mediterranean fever, colchicine is lifelong therapy at 1.2-2.4 mg daily. For acute pericarditis, treat for 3 months at 0.5 mg once or twice daily (based on body weight).
Acute Gout Treatment
The treatment duration for an acute gout flare is brief but specific. Administer the loading regimen (1.2 mg followed by 0.6 mg one hour later) only if symptoms began within 36 hours 1. After the initial loading dose, transition to prophylactic dosing (0.6 mg once or twice daily) starting 12 hours later and continue until the acute attack completely resolves 1. The 2017 ACP guidelines support this low-dose approach with strong evidence showing equal efficacy to higher doses with fewer gastrointestinal side effects 2.
The FDA label confirms this regimen: 1.8 mg total over one hour for acute treatment, with no benefit from higher doses 3. If a patient is already on prophylactic colchicine when a flare occurs, do not use colchicine for the acute flare—choose an alternative therapy like NSAIDs or corticosteroids 1.
Gout Prophylaxis Duration
Prophylaxis duration is tied to urate-lowering therapy (ULT) initiation and must continue for the greater of: (1) at least 6 months, OR (2) 3 months after achieving target serum urate 1.
- Without tophi: Continue for 3 months after reaching target serum urate
- With tophi present: Continue for 6 months after reaching target serum urate
The 2016 EULAR guidelines recommend prophylaxis during the first 6 months of ULT 4. Recent Korean data suggests that 3 months may be sufficient for maximizing XOI persistence, though 6 months remains the guideline standard 5. The FDA label states prophylactic therapy "may be beneficial for at least the first six months" 3.
Dosing for prophylaxis: 0.6 mg once or twice daily (maximum 1.2 mg/day) 1, 3. Outside the US where 0.5 mg tablets are available, use 0.5 mg once or twice daily 1.
Familial Mediterranean Fever (FMF)
Colchicine for FMF is lifelong therapy 6. The dose ranges from 1.2-2.4 mg daily in adults, titrated in 0.3 mg increments to control disease while minimizing side effects 3.
For pediatric patients:
- Ages 4-6 years: 0.3-1.8 mg daily
- Ages 6-12 years: 0.9-1.8 mg daily
- Ages >12 years: 1.2-2.4 mg daily 3
The EULAR FMF guidelines emphasize that discontinuation predisposes patients to acute attacks and amyloidosis development 6. Long-term studies confirm safety and efficacy over 15+ years of continuous use 7. Maximum safe doses are 3 mg daily in adults and 2 mg daily in children 6.
Acute Pericarditis
For acute pericarditis, colchicine duration is 3 months 8. The 2015 ESC guidelines specify 0.5 mg once daily for patients <70 kg or 0.5 mg twice daily for patients ≥70 kg 8.
Colchicine is added on top of aspirin or NSAIDs (not as monotherapy) and should be started with or shortly after anti-inflammatory therapy 8. Tapering is not mandatory but can be done in the final weeks (0.5 mg every other day for <70 kg or 0.5 mg once daily for ≥70 kg) 8. The 3-month duration is based on evidence showing reduced recurrence rates when colchicine is used as adjunctive therapy 9.
Critical Safety Considerations
Dose adjustments are mandatory in several scenarios:
- Renal impairment: Reduce doses; avoid in severe renal disease when using strong CYP3A4/P-gp inhibitors 2, 3
- Drug interactions: With strong CYP3A4 inhibitors (clarithromycin, ketoconazole, ritonavir), reduce prophylaxis dose to 0.3 mg once daily and acute treatment to 0.6 mg × 1 dose 3
- Hepatic impairment: Dose reduction required; colchicine half-life can increase sevenfold in cirrhosis 6
Maximum safe doses 6:
- Adults: 3 mg daily
- Children: 2 mg daily
Exceeding these doses or combining with interacting drugs can cause life-threatening toxicity with gastrointestinal symptoms progressing to multiorgan failure 6, 10. There is no antidote—management is purely supportive 6.
Common Pitfalls to Avoid
Do not use high-dose colchicine regimens (0.6 mg every hour for 6 hours)—these are obsolete and cause severe diarrhea without added benefit 2, 11
Do not start colchicine for acute gout if >36 hours have passed since symptom onset—efficacy is lost 1
Do not stop colchicine abruptly in FMF patients—this precipitates acute attacks and increases amyloidosis risk 6, 7
Do not combine colchicine with macrolides or strong CYP3A4 inhibitors without dose reduction—fatal toxicity has been reported with clarithromycin 3
Do not use prophylactic colchicine to treat an acute flare if already on prophylaxis—switch to alternative therapy 1